ArticleNPJ breast cancer2023

Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM).

Naoki Niikura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.